CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 365 enrolled
Drug / intervention
Transarterial chemoembolization (TACE) +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00493402
NCT00493402Phase 3Completed
CompareCT.gov

The Efficacy, Safety, and Patient Reported Outcomes of Different Regimens of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma

Sun Yat-sen University·interventional·Posted Jun 28, 2007·Updated Dec 17, 2012

In Brief

A Phase 3 clinical trial evaluating Transarterial chemoembolization (TACE) for Hepatocellular Carcinoma. Completed, enrolled 365 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate efficacy, safety, and patient reported outcomes (PRO) of different regimens of transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHepatocellular Carcinoma
CountriesChina
CollaboratorsMinistry of Health, China, Guangdong Provincial People's Hospital, The 458 Hospital of Chinese PLA, Kaiping Central Hospital

Timeline

Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 28, 2007
Enrollment StartJul 1, 2007
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 19.0 years ago

Interventions

Transarterial chemoembolization (TACE)procedure

drugs and dosage: chemotherapy with lipiodol mixed with EADM 50mg, lobaplatin 50mg, and MMC 6mg, plus particle embolization.

Transarterial chemoembolization (TACE)procedure

drugs and dosage: chemotherapy with lipiodol mixed with EADM 50mg, lobaplatin 50mg, and MMC 6mg.

Transarterial chemoembolization (TACE)procedure

Drugs and dosage:chemotherapy with lipiodol mixed with EADM 50mg, plus particle embolization.